Repligen Q2 revenue $207.6M (+27% YoY); raises FY 2022 guidance

REPLIGEN CORP

2022-Q2 EPS reported $1.68 revenue$414,033,000

Q2 revenue $207.6M, up 27% as reported, 32% constant currency; organic growth 29%.
GAAP diluted EPS $0.88 vs $0.64; adjusted EPS $0.91 vs $0.79, both YoY increases.
FY 2022 revenue guidance raised to $790-$810M from $770-$800M; adjusted EPS raised to $3.13-$3.20.
Base business grew 41% in Q2, led by Filtration and Chromatography franchises.
Cash $596.5M at June 30, 2022; gross margin 58.5% GAAP, 58.7% adjusted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.